Literature DB >> 4006134

Risk factors for the development of prosthetic valve endocarditis.

S B Calderwood, L A Swinski, C M Waternaux, A W Karchmer, M J Buckley.   

Abstract

Risk factors for the development of prosthetic valve endocarditis (PVE) were analyzed in 2642 patients undergoing initial valve replacement at the Massachusetts General Hospital from 1975 to 1982. Follow-up was available for 2608 patients (98.7%); the mean length of follow-up was 39.8 months. PVE developed in 116 patients (4.4%). The actuarial risk of PVE was 3.1% at 12 months and 5.7% at 60 months. A Cox model was used to identify risk factors for PVE. Recipients of multiple valves had a higher risk of PVE than single valves (p = .01). There was no difference in the risk of PVE for patients receiving aortic valves vs those receiving mitral valves. Recipients of mechanical valves had a higher risk of PVE than recipients of porcine valves in the first 3 months after surgery (p = .02), but the risk of PVE was higher for porcine valve recipients 12 months or more after surgery (p = .004). Despite this difference in the time course of development of PVE, there was no significant difference in the cumulative risk of PVE by 5 years of follow-up between mechanical and porcine valve recipients. Male sex was a risk factor for PVE within 12 months of aortic valve replacement (p = .008) but not thereafter; sex did not influence the risk of PVE after mitral valve replacement. Older patients had a higher risk of late PVE after multiple (p = .04) or mitral valve replacement (p = .08), but not after aortic valve replacement.

Entities:  

Mesh:

Year:  1985        PMID: 4006134     DOI: 10.1161/01.cir.72.1.31

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

Review 1.  Infections associated with indwelling devices: concepts of pathogenesis; infections associated with intravascular devices.

Authors:  G M Dickinson; A L Bisno
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

2.  Characterization of clinically significant isolates of Staphylococcus epidermidis from patients with endocarditis.

Authors:  J Etienne; Y Brun; N el Solh; V Delorme; C Mouren; M Bes; J Fleurette
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

3.  Native valve endocarditis caused by Staphylococcus simulans.

Authors:  B Jansen; F Schumacher-Perdreau; G Peters; G Reinhold; J Schönemann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

Review 4.  The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century.

Authors:  J Ambrosioni; M Hernandez-Meneses; A Téllez; J Pericàs; C Falces; J M Tolosana; B Vidal; M Almela; E Quintana; J Llopis; A Moreno; José M Miro
Journal:  Curr Infect Dis Rep       Date:  2017-05       Impact factor: 3.725

5.  Cardiovascular implantable device infections.

Authors:  George M Viola; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

Review 6.  Valve disease: Surgery of valve disease: late results and late complications.

Authors:  P Groves
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

7.  [Mechanical versus biological heart valves].

Authors:  J Ennker; A Lauruschkat
Journal:  Z Kardiol       Date:  2001-12

8.  Complementary role of cardiac computed tomography angiography in the diagnosis of prosthetic aortic valve endocarditis and septic coronary embolism - a case report.

Authors:  Thomas van den Boogert; Bimmer Claessen; Daniëlle Robbers-Visser; José Henriques; Nils Planken
Journal:  J Radiol Case Rep       Date:  2019-02-28

Review 9.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

10.  Prosthetic valve endocarditis. A survey.

Authors:  M Ben Ismail; N Hannachi; F Abid; Z Kaabar; J F Rougé
Journal:  Br Heart J       Date:  1987-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.